New research from the University of Michigan Comprehensive Cancer Center helps explain why pancreatic cancer is so lethal, with fewer than a third of patients surviving even early stage disease.
Jan 15, 2015
1
342
Even in remission, cancer looms. Former cancer patients and their doctors are always on alert for metastatic tumors. Now scientists at The Scripps Research Institute (TSRI) have discovered why some cancers may reoccur after ...
May 2, 2017
0
1821
Patients with an early form of breast cancer are less likely to suffer a recurrence if they are post-menopausal or if their tumour is oestrogen receptor positive, according to research presented at the 11th European Breast ...
Mar 21, 2018
0
14
Virtually all cervical cancers are caused by HPV, or human papillomavirus, dubbed the "common cold" of sexually transmitted infections because nearly every sexually active person catches it. Fortunately, the immune system ...
Jun 4, 2018
0
914
If you currently are sexually active, have been sexually active in the past or have sex in the future, there's an extremely high chance that at some point before your sex life is over you will have been infected with the ...
Apr 18, 2017
0
394
Giving people with bladder cancer chemotherapy and radiotherapy at the same time helps stop cancer from coming back, long-term results of a 10-year study confirm.
Aug 2, 2022
0
3
Scientists funded by Breast Cancer Now have confirmed inherited genetic links between non-invasive cancerous changes found in the milk ducts – known as ductal carcinoma in situ (DCIS) – and the development of invasive ...
Apr 12, 2016
0
103
Targeting a pathway that controls the movement of mitochondria, the powerhouses of all cells, could reduce cancer invasiveness and resistance to radiotherapy.
Sep 12, 2018
0
883
A strain of the common cold virus has been found to potentially target, infect and destroy cancer cells in patients with bladder cancer, a new study in the medical journal Clinical Cancer Research reports. No trace of the ...
Jul 5, 2019
3
10
Women who have a family history of breast cancer are set to benefit from a new genetic test at Manchester University NHS Foundation Trust (MFT) that assesses breast cancer risk, with plans for it to enter clinical practice ...
Oct 9, 2017
0
266
